Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma

ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO and OSAMU HATAJI
Anticancer Research November 2023, 43 (11) 5197-5204; DOI: https://doi.org/10.21873/anticanres.16721
ATSUSHI ITO
1Respiratory Center, Department of Thoracic Surgery, Matsusaka Municipal Hospital, Matsusaka, Japan;
2Department of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, Tsu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mchi.atsushi@city-hosp.matsusaka.mie.jp
TOMOHITO TARUKAWA
1Respiratory Center, Department of Thoracic Surgery, Matsusaka Municipal Hospital, Matsusaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTA SUZUKI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADASHI SAKAGUCHI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTARO ITO
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTARO FUJIWARA
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOICHI NISHII
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OSAMU TAGUCHI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROKI YASUI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MOTOSHI TAKAO
2Department of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, Tsu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OSAMU HATAJI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (11)
Anticancer Research
Vol. 43, Issue 11
November 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO, OSAMU HATAJI
Anticancer Research Nov 2023, 43 (11) 5197-5204; DOI: 10.21873/anticanres.16721

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO, OSAMU HATAJI
Anticancer Research Nov 2023, 43 (11) 5197-5204; DOI: 10.21873/anticanres.16721
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Clinicopathological and Molecular Insights into Primary Retroperitoneal Squamous Cell Carcinoma: HPV Association and Discovery of Recurrent PIK3CA E545K Mutation
  • MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
  • Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
  • Google Scholar

More in this TOC Section

  • Prediction of Severe Anemia and Neutropenia Induced by Abemaciclib in Patients With Breast Cancer
  • Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer
  • Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
Show more Clinical Studies

Similar Articles

Keywords

  • Lung adenocarcinoma
  • Lung squamous cell carcinoma
  • programmed cell death ligand-1
  • driver gene mutation
  • Immune checkpoint inhibitors
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire